Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study

• Published in: Journal of clinical oncology Vol. 27; no. 32; pp. 5376 - 5382
• Main Authors: LOBERIZA, Fausto R, CANNON, Anthony J, WEISENBURGER, Dennis D, VOSE, Julie M, MOEHR, Matt J, BAST, Martin A, BIERMAN, Philip J, BOCIEK, R. Gregory, ARMITAGE, James O
• Format: Journal Article
• Language: English
• Published: Alexandria, VA American Society of Clinical Oncology 10.11.2009
• Subjects: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Cause of Death; Female; Geography; Health Care Surveys - statistics & numerical data; Health Personnel; Hematologic and hematopoietic diseases; Humans; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Lymphoma - mortality; Lymphoma - therapy; Male; Medical sciences; Middle Aged; Nebraska; Original Reports; Retrospective Studies; Rural Population - statistics & numerical data; Survival Analysis; Tumors; Urban Population - statistics & numerical data; Young Adult; Nebraska; Human; Cancerology; Treatment; Lymphoproliferative syndrome; Malignant hemopathy; Disparity; Lymphoid neoplasm; Lymphoma; Survival; Cancer
• ISSN: 0732-183X; 1527-7755
• DOI: 10.1200/JCO.2009.22.0038

Health disparities exist according to an individual's place of residence. We evaluated the association between primary area of residence (urban v rural) according to treatment provider (university based v community based) and overall survival in patients with lymphoma and determined whether there are patient groups that could benefit from better coordination of care. Population-based, retrospective cohort study of 2,330 patients with centrally confirmed lymphoma from Nebraska and surrounding states and treated by university-based or community-based oncologists from 1982 to 2006. Among urban residents, 321 (14%) were treated by university-based providers (UUB) and 816 (35%) were treated by community-based providers (UCB). Among rural residents, 332 (14%) were treated by university-based providers (RUB), and 861 (37%) were treated by community-based providers (RCB). The relative risk (RR) of death among UUB, UCB, and RUB were not statistically different. However, RCB had a higher risk of death (RR, 1.37; 95% CI, 1.14 to 1.65; P = .01; and RR, 1.26; 95% CI, 1.06 to 1.49; P = .01) when compared with UUB and RUB, respectively. This association was true in both low- and intermediate-risk patients. Among high-risk patients, UCB, RUB, and RCB were all at higher risk of death when compared with UUB. Survival outcomes of patients with lymphoma may be associated with place of residence and treatment provider. High-risk patients from rural areas may benefit from better coordination of care.